Fundz

SciTech Development secures an oversubscribed $5.5 million Convertible Note Round to continue cancer clinical trials, driven by promising results for ST-001 nanoFenretinide™.

PRIVATESep 24, 2025

Amount Raised

$5.5 Million

Round Type

Funding Round

Grosse Pointe FarmsBiotechnologyHealth CarePharmaceutical

Description

SciTech Development, Inc. has successfully closed its Convertible Note Round #3 at $5.5 million, exceeding its $3.0 million target. This funding will support ongoing clinical trials for its lead drug ST-001 nanoFenretinide™. The impressive interim trial results have instilled significant investor confidence

Quick answer

SciTech Development raised $5.5 Million in a Funding Round round, dated September 24, 2025. SciTech Development is based in Grosse Pointe Farms, Michigan, United States.

How much did SciTech Development raise?
SciTech Development raised $5.5 Million in a Funding Round round on September 24, 2025.
What does SciTech Development do?
SciTech Development is a clinical-stage pharmaceutical company committed to advancing the next generation of cancer treatment.
Where is SciTech Development based and how big is it?
SciTech Development is based in Grosse Pointe Farms, Michigan, United States. Fundz records about 11 employees.
Who are the decision-makers at SciTech Development?
Fundz holds 1 contact at SciTech Development, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Biotechnology around the same time

Companies in the same sectors as SciTech Development that raised within 45 days of this round, from Fundz verified event records.

  • Pelthos Therapeutics raised $18M on November 6, 2025.
  • Shuttle Pharmaceutical Holdings raised $2.5M (Post-IPO Equity) on November 3, 2025.
  • Acasti raised $4M (Funding Round) on October 23, 2025.
  • ENA Respiratory raised $22M (Series B) on October 22, 2025.
  • Minerva Neurosciences raised $200M (Funding Round) on October 21, 2025.
  • ISOThrive raised $8.1M on October 10, 2025.

Who to call at SciTech Development, and when

A new round usually means SciTech Development is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SciTech Development raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SciTech Development, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SciTech Development. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SciTech Development

Location

281 KERCHEVAL AVE.

Grosse Pointe Farms, Michigan, United States

About

SciTech Development is a clinical-stage pharmaceutical company committed to advancing the next generation of cancer treatment. Leveraging its proprietary nanotechnology drug-delivery platform, the company has developed ST-001 nanoFenretinide™, a first-in-class drug currently in clinical trials for T-cell Non-Hodgkin Lymphoma. With its patented design and proven potential, ST-001 may be applicable across a broad range of additional cancers, offering hope for more effective and accessible treatment options.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SciTech Development raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsEarle H., Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for SciTech Development's next move

See what Strategic adds

SciTech Development raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.